Table 4.
Factors | OR (95 % CI) | p-value |
---|---|---|
Female age (years) | 0.930(0.872-0.993) | 0.031 |
No. of transferred TQE | 1.102(1.031-1.179) | 0.004 |
Developmental stage | 0.842(0.718-0.987) | 0.004 |
Progesterone elevation (ng/ml)ª | <0.001 | |
Developmental stageb PE (ng/ml) | ||
0-0.49 | 0.369 | |
0.50-0.74 | 0.099 | |
0.75-0.99 | 0.921 | |
1.00-1.24 | 0.828 | |
1.25-1.49 | 0.861 | |
1.50-1.74 | 0.799 | |
1.75-1.99 | 0.058 | |
2- | 0.228 |
Note: TQE: top-quality embryo; OR: odds ratio; CI: confidence interval. developmental stage: cleavage versus blastocyst stage, PEª was defined as an unordered categorical variable according to progesterone levels: <0.50, 0.50-074, 0.75-0.99, 1.00-1.24, 1.25-1.49, 1.50-1.74, 1.75-1.99 and ≥2.00 ng/ml. The 95 % CIs of developmental stage bPE were all covered 1